3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Dermatologic
1
Conditions
Carcinoma, Basal Cell
6
Lung Neoplasms
4
Skin Neoplasms
2
Precancerous Conditions
2
Pancreatic Neoplasms
2
Neoplasms
2
Keratosis, Actinic
2
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Telangiectasis
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rosacea
1
Recurrent respiratory papillomatosis
1
Prostatic Neoplasms
1
Port-Wine Stain
1
Pancreatic Intraductal Neoplasms
1
Non-melanoma Skin Cancer
1
Nevus, Pigmented
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Mouth Diseases
1
Mixed Tumor, Malignant
1
Mesothelioma, Malignant
1
Melanoma
1
Lichen Planus, Oral
1
Leukoplakia, Oral
1
Kidney Neoplasms
1
Interventions
Cyclophosphamide
54
Tacrolimus
50
Methotrexate
36
Mycophenolic Acid
34
fludarabine phosphate
33
Busulfan
31
Cyclosporine
29
fludarabine
28
Antilymphocyte Serum
28
Melphalan
23
Sirolimus
21
Whole-Body Irradiation
18
Radiotherapy
18
Peripheral Blood Stem Cell Transplantation
18
Methylprednisolone
18
Filgrastim
15
thymoglobulin
13
Thiotepa
10
Stem Cell Transplantation
9
Rituximab
9
Granulocyte Colony-Stimulating Factor
8
Hematopoietic Stem Cell Transplantation
7
Etoposide
7
Cord Blood Stem Cell Transplantation
7
Cytarabine
6
Alemtuzumab
6
ruxolitinib
5
Transplantation
5
Therapeutics
5
Prednisone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Graft vs Host Disease
×
Tomography, Optical Coherence
×
Clear all
NCT06321003
2025-05-23
SYMILIS OCT
University of Palermo
Recruiting
200 enrolled